Max Robotics — Global Service Robot Directory + US Certification

About

Tsutomu Chiba’s research spans the critical intersection of oncology and robotics, with a primary focus on improving outcomes for pancreatic cancer patients. His most cited work, a 2010 study on survival prediction for patients receiving gemcitabine treatment, tackles the challenge of variable drug response in advanced pancreatic cancer. By employing liquid chromatography-mass spectrometry (LC-MS) to identify novel biomarkers, Chiba’s team sought to personalize therapy and enhance prognostic accuracy—a contribution that has garnered 35 citations and underscores his commitment to precision medicine. Beyond the clinic, Chiba extends his engineering expertise to infrastructure safety, co-authoring a 2018 paper on the automatic inspection of embankments using crawler-type mobile robots. This work, presented at the International Symposium on Automation and Robotics in Construction, demonstrates his versatility in applying robotic systems to real-world monitoring tasks. While his citation counts reflect a focused but impactful career, Chiba’s dual contributions to cancer biomarker discovery and automated inspection highlight a unique ability to bridge biomedical research and practical robotics, offering valuable insights for students and researchers in both fields.